Physiologic evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis

被引:44
作者
Darbee, JC [1 ]
Ohtake, P
Grant, BJB
Cerny, FJ
机构
[1] SUNY Buffalo, Dept Phys Therapy Exercises & Nutr Sci, Buffalo, NY USA
[2] Univ Kentucky, Coll Hlth Sci, Div Phys Therapy, Dept Rehab Sci, Lexington, KY 40536 USA
来源
PHYSICAL THERAPY | 2004年 / 84卷 / 06期
关键词
airway clearance; chest physical therapy; cystic fibrosis; gas mixing; ventilation distribution;
D O I
10.1093/ptj/84.6.524
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background and Purpose. Individuals with cystic fibrosis (CF) have large amounts of infected mucus in their lungs, which causes irreversible lung tissue damage. Although patient-administered positive expiratory pressure (PEP) breathing has been promoted as an effective therapeutic modality for removing mucus and improving ventilation distribution in these patients, the effects of PEP on ventilation distribution and gas mixing have not been documented. Therefore, this preliminary investigation described responses in distribution of ventilation and gas mixing to PEP breathing for patients with moderate to severe CF lung disease. Subjects and Methods. The effects of PEP breathing on ventilation distribution, gas mixing, lung volumes, expiratory airflow, percentage of arterial blood oxyhemoglobin saturation (Spo(2)), and sputum volume were studied in 5 patients with CF (mean age=18 years, SD=4, range=13-22) after no-PEP, low-PEP (10-20 cur H2O), and high-PEP (>20 cm H2O) breathing conditions. Single-breath inert gas studies and lung function tests were performed before, immediately after, and 45 minutes after intervention. Single-breath tests assess ventilation distribution homogeneity and gas mixing by observing the extent to which an inspired test gas mixes with gas already residing in the lung. Results. Improvements in gas mixing were observed in all PEP conditions. By 45 minutes after intervention, the no-PEP group improved by 5%, the low-PEP group improved by 15%, and the high-PEP group improved by 23%. Slow vital capacity increased by 1% for no PEP, by 9% for low PEP, and by 13% for high PEP 45 minutes after intervention. Residual volume decreased by 13% after no PEP, by 20% after low PEP, and by 30% after high PEP. Immediate improvements in forced expiratory flow during the middle half of the forced vital capacity maneuver (FEF25%-75%) were sustained following high PEP but not following low PEP. Discussion and Conclusion. This study demonstrated the physiologic basis for the efficacy of PEP therapy. The results confirm that low PEP and high PEP improve gas mixing in individuals with CF, and these improvements were associated with increased lung function, sputum expectoration, and Spo(2). The authors propose that improvements in gas mixing may lead to increases in. oxygenation and thus functional exercise capacity.
引用
收藏
页码:524 / 537
页数:14
相关论文
共 38 条
[1]
ANDERSEN JB, 1979, SCAND J RESPIR DIS, V60, P260
[2]
EFFECT OF CYSTIC-FIBROSIS ON INHALED AEROSOL BOLUSES [J].
ANDERSON, PJ ;
BLANCHARD, JD ;
BRAIN, JD ;
FELDMAN, HA ;
MCNAMARA, JJ ;
HEYDER, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (05) :1317-1324
[3]
LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].
不详 .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218
[4]
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107
[5]
AIRWAY CLOSURE AS A FUNCTION OF AGE [J].
ANTHONISEN, NR ;
DANSON, J ;
ROBERTSON, PC ;
ROSS, WRD .
RESPIRATION PHYSIOLOGY, 1969, 8 (01) :58-+
[6]
SHORT-TERM EFFECTS OF 3 CHEST PHYSIOTHERAPY REGIMENS IN PATIENTS HOSPITALIZED FOR PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS - A CROSS-OVER RANDOMIZED STUDY [J].
BRAGGION, C ;
CAPPELLETTI, LM ;
CORNACCHIA, M ;
ZANOLLA, L ;
MASTELLA, G .
PEDIATRIC PULMONOLOGY, 1995, 19 (01) :16-22
[7]
Effect of ventilation distribution on aerosol bolus dispersion and recovery [J].
Brown, JS ;
Gerrity, TR ;
Bennett, WD .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (06) :2112-2117
[8]
BUIST AS, 1973, AM REV RESPIR DIS, V108, P1078
[9]
VARIABILITY OF PULMONARY-FUNCTION TESTS IN CYSTIC-FIBROSIS [J].
COOPER, PJ ;
ROBERTSON, CF ;
HUDSON, IL ;
PHELAN, PD .
PEDIATRIC PULMONOLOGY, 1990, 8 (01) :16-22
[10]
CRAPO RO, 1982, B EUR PHYSIOPATH RES, V18, P419